On the heels of Teladoc’s stock plunge, the co-founder of Livongo told Sarah he is disappointed, like the rest of the market, in the telehealth leader’s results.
Driving the news: During a fireside chat with Transcarent CEO Glen Tullman at ATA2022, Sarah asked the executive what went wrong after Teladoc bought virtual chronic care company Livongo in a $18.5 billion deal — digital health’s largest ever.
